VALIANT: A clinical research study for young people and adults with C3G or MPGN
VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).